viernes, 3 de enero de 2025

Primary Care Medication-Assisted Treatment for Opioid Use Disorder Grantees

https://integrationacademy.ahrq.gov/about/initiatives/opioid/grantees Call for AHRQ Impact Case Studies Do you use any of AHRQ’s tools and resources, such as the Practice Facilitation Training Modules? AHRQ is looking for new Impact Case Studies, which tell stories about how AHRQ’s tools and resources are being used by organizations nationwide to improve care and reduce costs. In addition to being posted online and promoted via our various communications channels, Impact Case Studies are shared with members of Congress and used in budget documents, fact sheets, and speeches by the AHRQ Director and senior leaders to demonstrate AHRQ’s impact on health care. Check out these real-world examples of the impact AHRQ's tools have had in a variety of facilities across the nation: How rural primary care practices in New Mexico have expanded on an AHRQ initiative to provide online training to prescribe proven medication-assisted treatment to patients with opioid use disorder (MAT for OUD, or MOUD). Online Training Enables Primary Care Providers in Rural New Mexico to Prescribe Medication for Opioid Use Disorders https://www.ahrq.gov/news/newsroom/case-studies/202304.html Why a learning health system used AHRQ tools to improve teamwork and reduce bloodstream infections for patients across Delaware, Maryland, New Jersey, and Pennsylvania. ChristianaCare Used AHRQ Resources to Reduce Blood Infections, Expedite Stroke Care https://www.ahrq.gov/news/newsroom/case-studies/202004.html How a university student health center in Georgia used AHRQ’s Medical Office Survey on Patient Safety Culture™ (SOPS®) to evaluate the safety culture and quality of its facility. University of Georgia Health Center Relies on AHRQ Survey to Assess Culture of Safety and Quality https://www.ahrq.gov/news/newsroom/case-studies/202303.html

New Year, new approach to weight loss: Almost three quarters of UK women are considering using GLP-1s in 2025

https://www.news-medical.net/news/20250103/New-Year-new-approach-to-weight-loss-Almost-three-quarters-of-UK-women-are-considering-using-GLP-1s-in-2025.aspx

Brazil's cash transfer program cuts tuberculosis cases and deaths among vulnerable populations

https://www.news-medical.net/news/20250103/Brazils-cash-transfer-program-cuts-tuberculosis-cases-and-deaths-among-vulnerable-populations.aspx

Real-world data: bridging the gap between clinical trials and practice

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00494-2/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz-9kQRAQ1y3EMr_FwSl8AeLBuRoTb0Z6QZGQ2d2OW8mT_te-V0pgDNkEYyx5GVDnalHVEy3Wo5ivJYK86Zah5KopTggkbA&_hsmi=340727090&utm_content=339174880&utm_source=hs_email

Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic review

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00493-0/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz-8pfWg4usymoALwZ-A7zkNjB5TQZ4Dlj8oCPBjkKsqp4naLg6sy18HRpj2fcPKKO5txMpkGX8no-BqinFpxpYSIwFJjxw&_hsmi=340727090&utm_content=339174880&utm_source=hs_email

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00553-4/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz--94R3g463pTPp2frpdGxeqCw1TwkAqrFIDjjupIKpFjPIUR0kwR_kkbOdPYbrcEcX7ClQh3cxGkV0M2jL_nh22GrklLg&_hsmi=340727090&utm_content=339174880&utm_source=hs_email

The Lancet Countdown on health and climate change

https://www.thelancet.com/countdown-health-climate?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-9ApMnK8kCOF0QiyCqBJ2x9IGv9TcIJO_aFu9DMnbbkxskgDuP_eOpbyCy6Jk1CLGSHRW1HOLNzTplUN4taBTmqkSSPlw&_hsmi=340724177&utm_content=339173481&utm_source=hs_email

Estimating the effect of annual PM2·5 exposure on mortality in India: a difference-in-differences approach

https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(24)00248-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz--5ZmBj91YLAyN4FUTs2e7Oa5WZeEuvXNSbfSS5dXPdF9UbOwLP2_40370yJoK_g729H-Vve-8opatMJd795cGqy8_CUA&_hsmi=340724177&utm_content=339173481&utm_source=hs_email

Ambient air pollution exposure and adult asthma incidence: a systematic review and meta-analysis

https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(24)00279-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-9sCADleD9nQ-mN2r9_5HAu1GwNuITC9kRWzmJP0o-9KUAtX8VN8UTF0FOwF2S28skZCKBFSLWWq1HeddHx_VG8IAYrMg&_hsmi=340724177&utm_content=339173481&utm_source=hs_email

Climate and health education in public health schools worldwide during 2023–24: a survey

https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(24)00284-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-9Lfhn49pIlKK9xfdHCNo7RdzEZNETt63tqcxWKx7q-7Y0DSB2kK7UtRi3gRBc78vjdWlFFPiUFna8o45vd1b8YklC_iA&_hsmi=340724177&utm_content=339173481&utm_source=hs_email

SAMHSA's Resources to Support the Behavioral Health Needs of the Military/Veteran Community

https://www.edgereg.net/er/Registration/StepRegInfo.jsp?ActivityID=43200&StepNumber=1&v=NTRjOGJjYWEtMGFjZS00ZGZkLTljMzEtZWQxMjljYmIxNGI2 SAMHSA’s Stacey Owens and Greg Crawford will present on the mental health challenges faced by individuals within the Service Members, Veterans and Families (SMVF) population who are experiencing homelessness, justice system involvement and incarceration, or poverty. They will be exploring the impact of substance abuse within these groups and the associated difficulties/challenges in their recovery after incarceration/homelessness along with sharing some of the resources SAMHSA can offer. The virtual workshop is to be held on Thursday, January 16, 2025, from 1 to 3 p.m. ET.

Advanced Manufacturing Technologies Designation Program December 2024

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/advanced-manufacturing-technologies-designation-program?utm_medium=email&utm_source=govdelivery

AHRQ Quality Indicator Tools for Data Analytics

https://www.ahrq.gov/data/qualityindicators/index.html

National Healthcare Quality and Disparities Report Data Tools

https://www.ahrq.gov/data/nhqdr.html

Medical Expenditure Panel Survey (MEPS)

https://www.ahrq.gov/data/meps.html

Healthcare Cost and Utilization Project (HCUP)

https://www.ahrq.gov/data/hcup/index.html

Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Program

https://www.ahrq.gov/data/cahps.html

Data Infographics AHRQ Research Data Infographics

https://www.ahrq.gov/data/infographics/index.html

MRSA Prevention Toolkit: ICUs & Non-ICUs

https://www.ahrq.gov/hai/tools/mrsa-prevention/toolkit/welcome.html

Overview of the National Action Alliance for Patient and Workforce Safety Vision, Mission, and Aims.

https://www.ahrq.gov/action-alliance/index.html

AHRQ's Healthcare Extension Service: State-Based Solutions to Healthcare Improvement

AHRQ's Healthcare Extension Service: State-Based Solutions to Healthcare Improvement: Applicants Sought for Healthcare Extension Cooperatives, National Coordinating Center, and National Evaluation Center Notices of Funding Opportunity are available for applicants seeking to join AHRQ’s recently launched Healthcare Extension Service: State-based Solutions for Healthcare Improvement:

AHRQ’s Surveys on Patient Safety Culture® Program: An Overview for New Users (Webcast) Date: January 15, 2025 Time: 1:00-1:30 p.m. ET

https://www.ahrq.gov/sops/events/webinars/sops-primer-011525.html

FDA’s Final Rule on the Implied Nutrient Content Claim “Healthy” Maintains Focus on Foods Rather than on Nutrients January 3, 2025 By Riëtte van Laack —

https://www.thefdalawblog.com/2025/01/fdas-final-rule-on-the-implied-nutrient-content-claim-healthy-maintains-focus-on-foods-rather-than-on-nutrients/?utm_source=rss&utm_medium=rss&utm_campaign=fdas-final-rule-on-the-implied-nutrient-content-claim-healthy-maintains-focus-on-foods-rather-than-on-nutrients

jueves, 2 de enero de 2025

OCE Conversations on Cancer, Cervical Cancer Treatment Innovation: A Collaborative Discussion January 14, 2025

https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/oce-conversations-cancer-cervical-cancer-treatment-innovation-collaborative-discussion-01142025?utm_medium=email&utm_source=govdelivery Webinar – Final Guidance: Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions January 14, 2025 https://www.fda.gov/medical-devices/cdrhnew-news-and-updates/webinar-final-guidance-marketing-submission-recommendations-predetermined-change-control-plan?utm_medium=email&utm_source=govdelivery

FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease

https://www.fda.gov/news-events/press-announcements/fda-approves-first-mesenchymal-stromal-cell-therapy-treat-steroid-refractory-acute-graft-versus-host?utm_medium=email&utm_source=govdelivery

FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers

https://www.fda.gov/news-events/press-announcements/fda-updates-healthy-claim-providing-refreshed-tool-consumers?utm_medium=email&utm_source=govdelivery

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities

https://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremities?utm_medium=email&utm_source=govdelivery

FDA Approves First Medication for Obstructive Sleep Apnea

https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea?utm_medium=email&utm_source=govdelivery

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes?utm_medium=email&utm_source=govdelivery

FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products

https://www.fda.gov/news-events/press-announcements/fda-proposes-rule-require-standardized-testing-methods-detecting-and-identifying-asbestos-talc?utm_medium=email&utm_source=govdelivery January 2, 2025 News At FDA FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products The FDA announced a proposed rule to establish and require standardized testing methods to detect and identify asbestos in talc-containing cosmetic products. This proposed rule, if finalized, will help protect consumers who use talc-containing cosmetic products from harmful exposure to asbestos. This proposal is part of the agency’s work to fulfill the requirements of section 3505 of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). https://www.federalregister.gov/documents/2024/12/27/2024-30544/testing-methods-for-detecting-and-identifying-asbestos-in-talc-containing-cosmetic-products

BsUFA III Regulatory Science Pilot Program: Progress Update January 22, 2025

https://www.fda.gov/drugs/news-events-human-drugs/bsufa-iii-regulatory-science-pilot-program-progress-update-01222025?utm_medium=email&utm_source=govdelivery

January is the Perfect Time to Pursue Treatment for a Substance Use Disorder

https://www.samhsa.gov/blog/january-perfect-time-pursue-treatment-substance-use-disorder?utm_source=SAMHSA&utm_campaign=47793b1ba2-EMAIL_CAMPAIGN_2024_12_27_04_27&utm_medium=email&utm_term=0_-47793b1ba2-167840245

Ending barriers to HIV care for migrant populations The Lancet HIV

https://www.thelancet.com/issue/S2352-3018(24)X0012-0

Despite available tools tuberculosis is the top killer again The Lancet Microbe

https://www.thelancet.com/issue/S2666-5247(24)X0013-0

COP29: incremental but insufficient progress on climate finance The Lancet Regional Health – Europe

https://www.thelancet.com/issue/S2666-7762(24)X0011-3

Eliminating tuberculosis by addressing access and equity The Lancet Regional Health – Southeast Asia

https://www.thelancet.com/issue/S2772-3682(24)X0012-8

Combating antimicrobial resistance: a shared responsibility of everyone The Lancet Regional Health – Western Pacific

https://www.thelancet.com/issue/S2666-6065(24)X0010-3

Reflecting on lessons from the 2014–16 Ebola virus outbreak The Lancet Infectious Diseases

https://www.thelancet.com/issue/S1473-3099(24)X0013-4

Harm reduction must replace punitive drug policies The Lancet Global Health

https://www.thelancet.com/issue/S2214-109X(24)X0013-3

A long STANDING commitment to improving health care The Lancet Digital Health

https://www.thelancet.com/issue/S2589-7500(24)X0013-8

Somebody has to move first The Lancet Planetary Health

https://www.thelancet.com/issue/S2542-5196(24)X0013-3

Saving the Skinny Label Through the Skinny Label, Big Savings Act January 2, 2025 By Sara W. Koblitz —

https://www.thefdalawblog.com/2025/01/saving-the-skinny-label-through-the-skinny-label-big-savings-act/?utm_source=rss&utm_medium=rss&utm_campaign=saving-the-skinny-label-through-the-skinny-label-big-savings-act

Advanced Manufacturing Technologies Designation Program December 2024

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/advanced-manufacturing-technologies-designation-program

miércoles, 1 de enero de 2025

Systemic Sickness: Over the past two decades, Black Americans have continued to suffer a higher mortality rate when compared to whites. Some suggest these health disparities stem from genetics and personal choices. But, as this series shows, behind many of the most pressing problems are federal, state and local government policies that have protected the interests of business and the powerful over the well-being of Black residents.

https://kffhealthnews.org/systemic-sickness/

Payback Tracking the Opioid Settlement Cash Opioid manufacturers, distributors, and retailers are

https://kffhealthnews.org/opioid-settlements/ Opioid manufacturers, distributors, and retailers are paying tens of billions of dollars in restitution to settle lawsuits about their role in the overdose epidemic, with little oversight on how the money is spent. We’re tracking how state and local governments use — or misuse — the cash.

Overpayment Outrage KFF Health News / Cox Media Group Investigation

https://kffhealthnews.org/overpayment-outrage/ The Social Security Administration has been overpaying billions of dollars to people, many on disability — then demanding the money back, even if the government made the mistake, an investigation by KFF Health News and Cox Media Group revealed. The reporting has triggered a congressional hearing, additional Senate oversight of the agency, an apology from the head of the SSA to Congress, and an ongoing internal policy review. In early 2024, the head of Social Security announced sweeping policy changes to address concerns about overpayments.

Dying Broke A KFF Health News-New York Times Project

https://kffhealthnews.org/dying-broke/ KFF Health News and The New York Times examine how the immense financial costs of long-term care drain older Americans and their families.

Diagnosis: Debt: More than 100 million people in America — a startling 41% of adults — are saddled with medical bills they cannot pay, according to a KFF Health News investigation with NPR and CBS News. The project exposed that medical debt — rather than fighting disease — is now a defining feature of the nation’s health care system.

https://kffhealthnews.org/diagnosis-debt/

In Year 7, ‘Bill of the Month’ Gives Patients a Voice December 30, 2024

https://kffhealthnews.org/news/article/bill-of-the-month-year-7-patients-fight-back-surprise-medical-bills/

Virtual reality program could boost your doctor’s empathy OtheReality, based on its teenage founder’s light-bulb moment in high school, aims to improve patient experiences and reduce medical staff burnout.

https://www.israel21c.org/virtual-reality-program-could-boost-your-doctors-empathy/

Temporal changes in Plasmodium falciparum genetic diversity and multiplicity of infection across three areas of varying malaria transmission intensities in Uganda

https://tropmedhealth.biomedcentral.com/

Tropical Diseases, Travel Medicine and Vaccines

https://tdtmvjournal.biomedcentral.com/

Aletha Maybank to step down as AMA’s chief health equity officer The departure may come as a surprise to health equity advocates who have lauded Maybank’s work

https://www.statnews.com/2024/12/30/aletha-maybank-ama-first-chief-health-equity-officer-steps-down/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-90zyQceCLKubVUvPMLi3X14zdhHzOuA8-frPmMrnvpAJmsT9RadejNC1fAWvxES0b_LOrSuqwHHUOtn552VFw4tsXsag&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

Extending Medicare coverage to obesity medications is imperative The Medicare prohibition on covering weight loss drugs is discriminatory and outdated Manage alerts for this article Email this article

https://www.statnews.com/2024/12/30/weight-loss-drugs-obesity-medication-glp-1s-medicare-coverage-cbo/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-8s6pfyFdpcKRs14pLis79Q64HwWHy41Gan3sscTNSNW5cm-2ZO4Z83uY9IS_F5ctr3jinsNkxrxQlEHNP1iFBcuFCivw&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results The company is developing the therapy for treatment of agitation associated with the condition

https://www.statnews.com/2024/12/30/axsome-therapeutics-alzheimers-disease-drug-trial-results/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--ySJLo4VRq7PENZ3h5Vt4toKD_oHU7XEPqBSvn_r_ytnRQbiA012zmZQmX300bNOgUKZsh-_1DDTsnrBXL8k8y8KJ7FQ&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

Fixing pulse oximeters requires federal might and possible legal action, researchers say Health equity leaders say inaction on the issue is endangering the lives of Black people

https://www.statnews.com/2024/12/30/fixing-pulse-oximeters-requires-federal-might-and-possible-legal-action-researchers-say/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--KKVrT6XyLWTMg3fgEyGtdNLzL2pKwFO4rcxAnRKFtkFG_gF2zxi8LYupfjgkgk-Ysm8waVR_ndf1lJIG4EKXIajRABA&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

The biggest medical advances of 2024 These drugs and procedures are changing the way we care for patients, and how they live

https://www.statnews.com/2024/12/30/top-medical-advances-2024-obesity-drugs-hiv-prevention-new-drug-schizophrenia/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--Ixtg3YRIETalIWKdDEJPaUsqNG_loogAU1rdhYeza05pVb5bHpaM3ClarLLjmLZ34SuDrb4eM39Xt_tIR-rib99LWjA&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

GOP works to square making America healthy with taking away health insurance Does health insurance make people healthy? Republicans return to an old debate in the MAHA era

https://www.statnews.com/2024/12/30/maha-make-america-healthy-again-faces-challenge-gop-deficit-hawks/

3 addiction and drug policy issues to watch in 2025 Trump’s return comes as Americans grow less tolerant of people with addiction

3 addiction and drug policy issues to watch in 2025 Trump’s return comes as Americans grow less tolerant of people with addiction https://www.statnews.com/2024/12/30/3-to-watch-series-chronic-disease-issues-2025-addiction-drug-policy-rfk-jr/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_2LSDIT_EgQ37SxRUttvwQabwH-PZFyU3p_jNsc30_WjPumU2vZpE5isd4OaUVeAn5g7OoPby0zi8AwvNotf7kmtX8xg&_hsmi=340542835&utm_content=340542835&utm_source=hs_email

The most read First Opinion essays of 2024 The UHC shooting, colonoscopy prep, compounded semaglutide, and more

https://www.statnews.com/2024/12/31/top-essays-2024-science-medicine-health-stat-first-opinion/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-8PaKsTpxFCfVT5YttU8yzYZkh2gNHC8oz6c7Uq7C1cH3XWoXHXrwW8C7w3uRUS2bJaLPoknWiKAHoFTkXXxWTLwsCY7g&_hsmi=340650889&utm_content=340650889&utm_source=hs_email

Pfizer kills hemophilia gene therapy deal, imperiling Sangamo Sangamo says it will seek new partner; options are dwindling

https://www.statnews.com/2024/12/30/hemophilia-pfizer-ends-gene-therapy-deal-with-sangamo/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--rVEiq9lSnqtlxu0NaR5hDoUAWkktwt094-lYZ6Scu9XV1L_mHm9vKo9innatWMPe-ROUgrU224WFMleqmKmbqmppUUA&_hsmi=340650889&utm_content=340650889&utm_source=hs_email

3 key issues to watch at the FDA as Trump takes office FDA will have a lot on its plate, from food additives to compounding regulation to AI

https://www.statnews.com/2024/12/31/key-issues-to-watch-fda-in-2025-compounding-ai-user-fees-food-additives-marty-makary-rfk-jr/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--qVAWhupyTz28qr6ViItmbJximnECN2wEra6Dv7JLQcxHvKkb_B_AP6Jx6hRbey3XENxnIgJhmrvipuX1Yh7M7gplMkg&_hsmi=340650889&utm_content=340650889&utm_source=hs_email

Four digital health unicorns on what they expect in 2025 Leaders from Omada, Transcarent, Hinge Health, and Maven Clinic reflect on 2024, and look ahead

https://www.statnews.com/2024/12/31/digital-health-unicorns-omada-transcarent-hinge-maven-trends-2025/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-90VV2TFCeddpXgy2RWbs8oSaeZ8GerJ9pr4FRwt543OogkdsVBuhJ3Y_lNt8le0Wf7CJYLhhp0Rw7aQckWJvOY1jFuSA&_hsmi=340650889&utm_content=340650889&utm_source=hs_email